{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:35:16Z","timestamp":1790087716920,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Rijeka, Croatia","award":["13.06.1.3.39"],"award-info":[{"award-number":["13.06.1.3.39"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","plefa.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.plefa.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,6,28]],"date-time":"2015-06-28T00:49:27Z","timestamp":1435452567000},"page":"29-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Polymorphisms in PLA2G6 and PLA2G4C genes for calcium-independent phospholipase A2 do not contribute to attenuated niacin skin flush response in schizophrenia patients"],"prefix":"10.1016","volume":"100","author":[{"given":"S.","family":"Nadalin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Radovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bureti\u0107-Tomljanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2015.06.004_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","article-title":"The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study","volume":"62","author":"Messamore","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2015.06.004_bib2","first-page":"14","article-title":"Niacin skin flush test: a research tool for studying schizophrenia","volume":"22","author":"Nadalin","year":"2010","journal-title":"Psychiatr. Danubina"},{"key":"10.1016\/j.plefa.2015.06.004_bib3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0278-5846(03)00152-0","article-title":"On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis","volume":"27","author":"Maclean","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2015.06.004_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4065\/mcp.2009.0535","article-title":"A \u201chot\u201d topic in dyslipidemia management \u2013 \u201chow to beat a flush\u201d: optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention","volume":"85","author":"Jacobson","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.plefa.2015.06.004_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.plefa.2005.02.007","article-title":"Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia","volume":"72","author":"Smesny","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2015.06.004_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0952-3278(96)90139-8","article-title":"Membrane fatty acids, niacin flushing and clinical parameters","volume":"55","author":"Glen","year":"1996","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2015.06.004_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.schres.2010.03.025","article-title":"Niacin sensitivity and the arachidonic acid pathway in schizophrenia","volume":"122","author":"Messamore","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2015.06.004_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.plefa.2012.11.005","article-title":"The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients","volume":"88","author":"Nadalin","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2015.06.004_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.schres.2006.11.027","article-title":"Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications","volume":"91","author":"McNamara","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2015.06.004_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2012.08.014","article-title":"A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia","volume":"141","author":"van der Kemp","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2015.06.004_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.mp.4001819","article-title":"The role of phospholipases A2 in schizophrenia","volume":"11","author":"Law","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.plefa.2015.06.004_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1388-1981(00)00107-4","article-title":"Calcium-independent phospholipase A(2): structure and function","volume":"1488","author":"Winstead","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plefa.2015.06.004_bib13","first-page":"213","article-title":"The ABC\u05f3s of Group IV cytosolic phospholipase A2","volume":"2004","author":"Lucas","year":"1636","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plefa.2015.06.004_bib14","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/sj.bjp.0705326","article-title":"Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+","volume":"139","author":"Strokin","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.plefa.2015.06.004_bib15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1471-4159.2010.07033.x","article-title":"Phospholipases A2 and neural membrane dynamics: implications for Alzheimer\u05f3s disease","volume":"116","author":"Lee","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.plefa.2015.06.004_bib16","doi-asserted-by":"crossref","first-page":"29526","DOI":"10.1074\/jbc.M204856200","article-title":"Enzymatic properties of human cytosolic phospholipase A(2)gamma","volume":"277","author":"M. Ghosh","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2015.06.004_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jb\/mvi067","article-title":"Roles of C-terminal processing, and involvement in transacylation reaction of human group IVC phospholipase A2 (cPLA2gamma)","volume":"137","author":"Yamashita Kamata","year":"2005","journal-title":"J. Biochem."},{"key":"10.1016\/j.plefa.2015.06.004_bib18","first-page":"1011","article-title":"Subcellular localization and lysophospholipase\/transacylation activities of human group IVC phospholipase A2 (cPLA2gamma)","volume":"2009","author":"Yamashita Tanaka","year":"1791","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plefa.2015.06.004_bib19","first-page":"1103","article-title":"Control of free arachidonic acid levels by phospholipases A2 and lysophospholipid acyltransferases","volume":"2009","author":"P\u00e9rez-Chac\u00f3n","year":"1791","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plefa.2015.06.004_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-3223(87)90164-8","article-title":"Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy","volume":"22","author":"Gattaz","year":"1987","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2015.06.004_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00041444-200409000-00007","article-title":"Allelic association analysis of phospholipase A2 genes with schizophrenia","volume":"14","author":"Junqueira","year":"2004","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.plefa.2015.06.004_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajmg.b.30210","article-title":"Cytosolic PLA2 gene possibly contribute to the etiology of schizophrenia","volume":"137","author":"Tao","year":"2005","journal-title":"Am. J. Med. Genet. B"},{"key":"10.1016\/j.plefa.2015.06.004_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.plefa.2005.07.003","article-title":"A genetic study of two calcium-independent cytosolic PLA2 genes in schizophrenia","volume":"73","author":"Yu","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2015.06.004_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/schbul\/sbl038","article-title":"SS, et al, Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives","volume":"33","author":"Lin","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.plefa.2015.06.004_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1034\/j.1399-5618.2003.00025.x","article-title":"Allelic association study between phospholipase A2 genes and bipolar affective disorder","volume":"5","author":"Meira-Lima","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.plefa.2015.06.004_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(97)00100-X","article-title":"Niacin skin flush in schizophrenia: a preliminary report","volume":"29","author":"Ward","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2015.06.004_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0278-5846(01)00220-2","article-title":"A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia","volume":"26","author":"Puri","year":"2002","journal-title":"Prog. Neuropsychopharmacol Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2015.06.004_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.plefa.2008.04.006","article-title":"BanI polymorphism of cytosolic phospholipase A2 gene is associated with age at onset in male patients with schizophrenia and schizoaffective disorder","volume":"78","author":"Nadalin","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2015.06.004_bib29","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1172\/JCI36806","article-title":"beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice","volume":"119","author":"Walters","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2015.06.004_bib30","first-page":"29","article-title":"The niacin flush pathway in recovery from schizophrenia and how arginine and glutamine may provide added benet","volume":"27","author":"Penberthy","year":"2012","journal-title":"J. Orthomol. Med."},{"key":"10.1016\/j.plefa.2015.06.004_bib31","first-page":"988","article-title":"Niacin-respondent subset of schizophrenia \u2013 a therapeutic review","author":"Xu","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.plefa.2015.06.004_bib32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2011.07.009","article-title":"Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder","volume":"44","author":"Bychkov","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.plefa.2015.06.004_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/mp.2011.131","article-title":"Potential metabolite markers of schizophrenia","volume":"18","author":"Yang","year":"2013","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.plefa.2015.06.004_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainresbull.2008.03.015","article-title":"The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia","volume":"77","author":"Miller","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.plefa.2015.06.004_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0169-328X(99)00343-5","article-title":"New dopamine receptor, D2 (Longer), with unique TG splice site, in human brain","volume":"76","author":"Seeman","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.plefa.2015.06.004_bib36","doi-asserted-by":"crossref","first-page":"15873","DOI":"10.1073\/pnas.0903413106","article-title":"DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms","volume":"106","author":"Nakata","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2015.06.004_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2013.00021","article-title":"Development-related alternative splicing of PAC1 receptor: a key player in schizophrenia?","volume":"6","author":"Rocha-Martins","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.plefa.2015.06.004_bib38","article-title":"MicroRNA and Posttranscriptional Dysregulation in Psychiatry","author":"Geaghan","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2015.06.004_bib39","first-page":"10","article-title":"Niacin Therapy in Psychiatry","author":"Hoffer","year":"1962"},{"key":"10.1016\/j.plefa.2015.06.004_bib40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.schres.2013.03.026","article-title":"Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia","volume":"147","author":"Kerr","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2015.06.004_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","article-title":"Increased phospholipase A2 activity in schizophrenia with absent response to niacin","volume":"61","author":"Tavares","year":"2003","journal-title":"Schizophr. Res."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327815001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327815001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T14:21:12Z","timestamp":1542291672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327815001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":41,"alternative-id":["S0952327815001349"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2015.06.004","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphisms in PLA2G6 and PLA2G4C genes for calcium-independent phospholipase A2 do not contribute to attenuated niacin skin flush response in schizophrenia patients","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}